Page 70 - GALENIKA MEDICAL JOURNAL

15. Mehta J, Kling JM, Manson JE. Risks, Benefits, and Treatment Modalities 27. Palacios S. Medical treatment of osteoporosis. Climacteric. 2022
of Menopausal Hormone Therapy: Current Concepts. Front Endocrinol Feb;25(1):43-9.
(Lausanne). 2021 Mar 26;12:564781.
28. Gosset A, Pouillès JM, Trémollieres F. Menopausal hormone therapy for
16. Xiao PL, Cui AY, Hsu CJ, Peng R, Jiang N, Xu XH, et al. Global, regional the management of osteoporosis. Best Pract Res Clin Endocrinol Metab.
prevalence, and risk factors of osteoporosis according to the World 2021 Dec;35(6):101551.
Health Organization diagnostic criteria: a systematic review and meta-
analysis. Osteoporos Int. 2022 Oct;33(10):2137-53. 29. Rozenberg S, Vandromme J, Revercez P, Valcarenghi M, Joris A.
Menopause Hormone Therapy in the Management of Postmenopausal
17. Gopinath V. Osteoporosis. Med Clin North Am. 2023 Mar;107(2):213-25. Osteoporosis. Cancer J. 2022 May-Jun 01;28(3):204-7.
18. Anam AK, Insogna K. Update on Osteoporosis Screening and 30. Brown JP. Long-Term Treatment of Postmenopausal Osteoporosis.
Management. Med Clin North Am. 2021 Nov;105(6):1117-34. Endocrinol Metab (Seoul). 2021 Jun;36(3):544-52.
19. Yong EL, Logan S. Menopausal osteoporosis: screening, prevention and 31. LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ,
treatment. Singapore Med J. 2021 Apr;62(4):159-66. et al. The clinician's guide to prevention and treatment of osteoporosis.
Osteoporos Int. 2022 Oct;33(10):2049-102.
20. Kanis JA, Cooper C, Rizzoli R, Reginster JY. Scientific Advisory Board of
the European Society for Clinical and Economic Aspects of Osteoporosis 32. McPhee C, Aninye IO, Horan L. Recommendations for Improving
(ESCEO) and the Committees of Scientific Advisors and National Women's Bone Health Throughout the Lifespan. J Womens Health
Societies of the International Osteoporosis Foundation (IOF). European (Larchmt). 2022 Dec;31(12):1671-6.
guidance for the diagnosis and management of osteoporosis in
postmenopausal women. Osteoporos Int. 2019 Jan;30(1):3-44. 33. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, et al.
Osteoporosis: A Review of Treatment Options. P T. 2018 Feb;43(2):92-
21. Föger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, 104.
Pietschmann P. Osteoporosis: Pathophysiology and therapeutic
options. EXCLI J. 2020 Jul 20;19:1017-37. 34. Management of osteoporosis in postmenopausal women: the 2021
position statement of The North American Menopause Society.
22. Lin YH, Shih YT, Teng MMH. The Impact of the "Osteo" Component of Menopause. 2021 Sep 1;28(9):973-97.
Osteosarcopenia on Fragility Fractures in Post-Menopausal Women. Int
J Mol Sci. 2021 May 17;22(10):5256. 35. Zhu J, March L. Treating osteoporosis: risks and management. Aust
Prescr. 2022 Oct;45(5):150-7.
23. Zanker J, Duque G. Osteosarcopenia: the Path Beyond Controversy. Curr
Osteoporos Rep. 2020 Apr;18(2):81-4.
24. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A Declaration of interest statement: None
comprehensive overview on osteoporosis and its risk factors. Ther Clin
Risk Manag. 2018 Nov 6;14:2029-49. Received: 14. 02. 2024.
25. Arceo-Mendoza RM, Camacho PM. Postmenopausal Osteoporosis: Accepted: 28. 02. 2024.
Latest Guidelines. Endocrinol Metab Clin North Am. 2021 Jun;50(2):167- Online: 31. 03. 2024.
78.
26. Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-
Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E. Current Status of the
Diagnosis and Management of Osteoporosis. Int J Mol Sci. 2022 Aug
21;23(16):9465.

68 DOI: 10.5937/Galmed2409072B